Biobank Market Overview
The global Biobank Market is experiencing strong growth as demand for high-quality biological samples and associated data continues to increase across biomedical research, drug discovery, precision medicine, and genomics. Growing investments in life sciences research, expanding biobanking infrastructure, and increasing use of human biological specimens in research are supporting market expansion.
The market was valued at approximately USD 48 billion in 2024 and is projected to grow from USD 51 billion in 2025 to USD 90 billion by 2035, registering a CAGR of 6.5% from 2026 to 2035. North America represents a leading regional market, supported by substantial investment in biotechnology and advanced healthcare research infrastructure. By specimen type, Blood Samples represent a major segment due to their extensive use in diagnostics, genomic studies, biomarker discovery, and pharmaceutical research.
Unlock Exclusive Insights – Request Your Free Sample Report Now!
https://www.wiseguyreports.com/sample-request?id=652904
Key Companies in the Biobank Market
Thermo Fisher Scientific
QIAGEN
BioLifeSolutions
Brooks Life Sciences
Hamilton Company
Azenta
Tecan
Eppendorf
Merck KGaA
STEMCELL Technologies
Charles River Laboratories
BioCision
Lonza
Labcorp
Eurofins Scientific
The increasing adoption of precision medicine and personalized healthcare is a major factor driving demand for biobanks. Pharmaceutical and biotechnology companies increasingly rely on well-characterized biological samples to support drug discovery, biomarker research, clinical studies, and disease research. Growing genomic research, increasing prevalence of chronic diseases, and investments in population-based biobanking initiatives are further supporting market development. Advances in automated sample storage, laboratory information management systems, and digital sample tracking are also improving biobank efficiency.
The market is segmented by Specimen Type into Blood, Tissue, Cells, DNA, and Other Biological Samples; by Application into Drug Discovery, Genomics Research, Clinical Research, Personalized Medicine, and Disease Research; by Type into Population-Based Biobanks, Disease-Oriented Biobanks, and Tissue Banks; by Ownership into Academic and Research Institutions, Hospitals, Pharmaceutical and Biotechnology Companies, and Private Organizations; and by Storage Type into Automated Storage Systems, Manual Storage Systems, and Cryogenic Storage. Regional segmentation covers North America, Europe, Asia Pacific, South America, and the Middle East and Africa.
Recent Developments and Market Trends:
The growing adoption of precision medicine is increasing demand for high-quality and well-characterized biological samples.
Automated sample storage systems are improving the efficiency, scalability, and accuracy of biobank operations.
Artificial intelligence and advanced data analytics are supporting more efficient analysis of biological and clinical datasets.
Cloud-based biobank management platforms are improving sample tracking, data accessibility, and collaboration between research organizations.
Population-based biobanking initiatives are expanding as governments and research institutions invest in large-scale genomic and health studies.
Increasing collaboration between pharmaceutical companies, academic institutions, and biobanks is accelerating biomarker and drug discovery research.
Reasons to Buy the Report:
Understand the market size, growth trajectory, and forecast through 2035.
Analyze specimen type, application, biobank type, ownership, storage type, and regional market segments.
Identify key market drivers, opportunities, challenges, and emerging biobanking trends.
Evaluate the competitive landscape and strategies of leading biobank technology and service providers.
Assess regional growth opportunities across established and emerging life sciences markets.
Future Outlook:
The Biobank Market is expected to maintain strong growth through 2035 as precision medicine, genomics, drug discovery, and biomedical research continue to expand. Increasing investments in biological sample repositories, automated storage technologies, digital data management, and population health research are expected to create sustained demand. North America is likely to remain a major market, while Asia Pacific is expected to offer significant opportunities as research infrastructure, biotechnology investment, and healthcare capabilities continue to develop.
➤➤Explore Our Latest Related Reports:
